Wed.May 21, 2025

article thumbnail

Lilly’s former small molecule head makes the leap to a rising biotech in obesity

PharmaVoice

Utpal Singh joined the peptide-focused biotech Zealand Pharma last month after it notched a massive obesity deal with Roche.

179
179
article thumbnail

FDA to Restrict Future COVID-19 Vaccine Recommendations to Older Adults, High-Risk Groups

Pharmacy Times

In a major policy shift, officials from the FDA announced a new regulatory framework for COVID-19 vaccinations, prioritizing adults aged 65 and older and individuals with serious comorbidities putting them at high risk for severe COVID-19.

Vaccines 132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK trumpets £1bn investment plan from BioNTech

pharmaphorum

BioNTech has said it will commit up to 1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector

105
105
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

After rallying for several days in a row, UnitedHealth Group's shares are taking another downturn following media reports that it paid kickbacks to nursing homes to reduce patient transfers to hospitals.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Zanidatamab Plus Chemotherapy Shows Promising Anti-Tumor Activity in Treatment of HER2-Mutated Breast Cancer

Pharmacy Times

The data were presented at the ESMO Breast Cancer 2025 Annual Meeting.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The Improving Seniors' Timely Access to Care Act seeks to streamline the prior auth process in Medicare Advantage, which would ease administrative burdens on providers and reduce delays in accessing care for patients.

83

More Trending

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Despite all the AI hype, most healthcare organizations are stuck in pilot mode. This week on "Podnosis," Fierce Healthcare Executive Editor Heather Landi explores why so few projects scale and what moving from promise to progress will take.

90
article thumbnail

Managing Opioid Complexity: The Role of Pharmacists in OUD and C-POD Care

Pharmacy Times

In a session at the 2025 Virtual Conference on Pain and Palliative Care, Isabella Zerfas, PharmD, and Abbey Galligan, PharmD, BCPS, explore effective pain management strategies for opioid use disorder (OUD) and complex persistent opioid dependence.

73
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Microsoft is testing out a new product that coordinates healthcare AI agents to support multi-disciplinary teams. Its first use case is for assisting tumor boards with reviewing images, lab tests and EMR data.

89
article thumbnail

WeightWatchers scraps business model to team up with anti-obesity drugs provider

The Guardian - Pharmaceutical Industry

Brand shifts away from dieting towards weight-loss injections after filing for bankruptcy in the US WeightWatchers is teaming up with a provider of weight-loss drugs such as Wegovy and Mounjaro, in a seismic shift for the brand away from a focus on dieting as it tries to turn around its struggling business. WeightWatchers, which has promoted a non-medical, points-based approach to food intake since its creation in the 1960s , has announced a strategic partnership in the UK with CheqUp, a provide

69
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Individuals would find it easier to access benefits from health savings accounts, direct primary care arrangements and ICHRA plans, if the current budget bill rolling through Congress is signed into law.

77
article thumbnail

Study Finds Increased Risk of CVD Among Women With History of Infertilty

Pharmacy Times

The risk of cardiovascular disease (CVD) was higher among those who were exposed to assisted reproductive technology.

65
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Watershed is already live in four other states with 9 million lives on the platform, which facilitates transitions of care, referrals for services and more.

93
article thumbnail

UK to start "world first" gonorrhoea vaccine programme

pharmaphorum

UK to start "world first" gonorrhoea vaccine programme Phil.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Lucy Phan Vo, PharmD, BCPS, BCEMP, on Advancing Pharmacy Practice Through Education

Pharmacy Times

Vo discusses how research and mentorship can enhance practice and patient care.

article thumbnail

The growth of radiotherapeutics: Addressing supply chain complexity

pharmaphorum

Players, current and emergent, should prepare for complexities in the supply chain as radiotherapeutics continues to rise.

64
article thumbnail

Denosumab With Ovarian Function Suppression and Aromatase Inhibitor Therapy in ER-Positive, Early-Stage Breast Cancer

Pharmacy Times

In premenopausal women, denosumab significantly prevented bone loss and microarchitectural deterioration.

65
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The macro "noise" in the market right now impacts payers and providers and could create headwinds for health tech and digital health companies as well. But some health tech players say they are well-positioned to weather any market volatility.

64
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Experts Share 2025 Pneumococcal Vaccination Guideline Recommendations for Children, Adolescents, and Adults

Pharmacy Times

Experts emphasize the importance of tailored vaccination strategies for pneumococcal based on individual risk factors.

article thumbnail

Top Email Marketing Platforms for Pharma: A 2025 Review of Compliant, High-Performing Tools

Pharma Marketing Network

Pharma email marketing platforms are no longer just digital toolstheyre the nerve center of healthcare communications in 2025. As more pharmaceutical brands race to connect with healthcare professionals (HCPs), payers, and patients in a compliant, data-driven way, the right platform makes all the difference. But how do you pick a platform that not only delivers strong ROI but also ensures HIPAA compliance, consent management, and CRM integration?

HIPAA 52
article thumbnail

FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research

Pharmaceutical Commerce

In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.

article thumbnail

Lead Gen in Pharma: Proven Strategies That Actually Convert

Pharma Marketing Network

Is your pharma brand generating leadsor just collecting contact forms? In a space as regulated and complex as pharmaceutical marketing, Lead Gen isnt just about volume. Its about conversion, compliance, and strategic targeting of healthcare professionals (HCPs), payers, and sometimes patients. While many life sciences companies continue to invest in email sign-ups and gated assets, far fewer have a consistent lead nurturing strategy that turns those leads into meaningful engagements or qualified

HIPAA 52
article thumbnail

FDA to restrict Covid-19 booster doses to older adults

Pharmaceutical Technology

The US Food and Drug Administration (FDA) is set to restrict the Covid-19 booster doses to older adults and those at risk of severe illness.

FDA 52
article thumbnail

Zuranolone in Postpartum Depression

Pharmacy Times

The treatment could hold significant potential for major depressive disorder

65
article thumbnail

Beckley's psychedelic med inches forward in depression

pharmaphorum

UK psychedelic medicines developer Beckley Psytech has said its candidate for treatment-resistant depression has enhanced the effect of standard antidepressants in a phase 2 trial.The top-line data comes from the next stage (Part 2) of its ongoing trial looking at a single dose of Beckley's BPL-003 in 12 patients given on top of standard SSRI antidepressant therapy.

51
article thumbnail

LogiPharma Europe 2025: How Digitization Drives End to End Supply Chain Success

Pharmaceutical Commerce

Ruth Beadle, head, global supply chain, Sanofi, discusses how digital integration, advanced planning, and sustainability goals are transforming end-to-end supply chain operations to improve scale, speed, and environmental impact.

52
article thumbnail

Viz.ai, Sanofi and Regeneron to link for COPD management

Pharmaceutical Technology

Viz.ai is set to enter into a multi-year collaboration with Sanofi and Regeneron for the management of COPD.

52
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 drugs.

53
article thumbnail

BioNTech to invest up to $1.34bn in UK R&D

Pharmaceutical Technology

BioNTech has entered a grant agreement with the UK government to expand its research and development (R&D) activities for medicines.

52
article thumbnail

Challenging conventional wisdom on injectables, with Mehul Desai

pharmaphorum

Watch an insightful video interview with Mehul Desai as he challenges conventional wisdom on injectables and shares his unique perspective on the topic. Gain new insights and knowledge in this engaging conversation.

52
article thumbnail

ATS 2025: GSK strengthens argument for twice-annual depemokimab

Pharmaceutical Technology

Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary for response.

52
article thumbnail

Merck’s Oral TLR7/8 Inhibitor Reduces Disease Activity in Cutaneous, Systemic Lupus

PharmExec

Results from the Phase II WILLOW trial show that enpatoran achieved a statistically significant dose-response and clinically meaningful reduction in disease activity in cutaneous and systemic lupus erythematosus with active rash.

40
article thumbnail

WHO secures 20% funding increase amid US shortfall

Pharmaceutical Technology

Despite the boost to contributions, WHO has downsized its 2026-27 budget by over $1bn due to financial constraints.

52